Law360, New York (May 02, 2012, 6:48 PM ET) -- In its first acquisition in the medical device industry, Johnson & Johnson (China) Investment Ltd. scooped up a Chinese biopharmaceutical company that makes a protein sealant used to control bleeding during surgery, the health care giant announced Wednesday.
The deal gives New Jersey-based Johnson & Johnson the privately held Guangzhou Bioseal Biotech Co. Ltd., headquartered in China's Guangdong province, according to a statement Johnson & Johnson issued Wednesday.
The buyer did not disclose the terms of the deal. Representatives for the parties were not immediately available...
J&J China Enters Medical Device Market With Bioseal Buy
To view the full article, take a free trial now.
